A CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH AGONIST TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS
CAMCEVI® is the first sub-Q leuprolide that comes prefilled with no mixing. In an open-label, single-arm study of 137 adults who received 42 mg of CAMCEVI on Day 0 and Week 24, CAMCEVI offered consistent testosterone suppression to castrate levels, after the initial injection, from Week 4 to Week 48.1See how simple syringe prep can be
HAVE A QUESTION?
Let us simplify it for you.CONNECT WITH A REPRESENTATIVE